International Business Machines Corporation (NYSE: IBM) has had a turbulent year. The stock climbed to a record close of $329.23 in early June 2026, only to fall roughly 25% in a single session on July 14 after preliminary second-quarter results disappointed. The shares now trade near $230, well below that peak. In that context, a $350 price target represents more than a simple recovery—it implies IBM would need to regain its lost ground and push to an all-time high.
IBM is a diversified enterprise technology company, not an exchange-traded fund (ETF), so its price outlook depends on the fundamentals of its software, consulting, and infrastructure businesses. The company grew revenue 8% in 2025 to $67.5 billion and generated $14.7 billion in free cash flow (FCF), the cash left after operating expenses and capital spending. That momentum continued into early 2026, when first-quarter revenue rose 9% and software revenue jumped 11%.
The second quarter broke that pattern. Revenue of $17.2 billion rose only 1% year over year. Software growth slowed to 5%, consulting was flat, and infrastructure fell 7%, dragged down by a 42% decline in the IBM Z mainframe business as a product cycle wound down. Management lowered its 2026 constant-currency revenue guidance to 4%–5%.
Cash generation has held up better than revenue. IBM still expects free cash flow of about $15.7 billion in 2026, supporting a quarterly dividend of $1.69 per share—its 31st consecutive annual increase—and a yield near 3%.
The bullish case rests on IBM's pivot toward higher-margin software and artificial intelligence (AI). Its generative AI backlog reached $12.5 billion in late 2025, and the watsonx platform plus the Red Hat open-source software franchise give the company a credible enterprise AI story. Acquisitions such as HashiCorp, and the pending Confluent deal, are designed to strengthen hybrid-cloud and data-streaming capabilities.
Quantum computing is the longer-term wild card. IBM has committed more than $10 billion to quantum research over five years, targeting a fault-tolerant system by 2029. Analysts at firms including Wedbush and Goldman Sachs have cited both the AI and quantum roadmaps when publishing price targets of $350 to $365. For IBM to reach $350, software growth would likely need to return to double digits, consulting would need to stabilize, and free cash flow would need to keep expanding toward the roughly $16.25-per-share level management has signaled.
The clearest obstacle is the slowdown that triggered July's sell-off. If software growth remains in the mid-single digits and consulting stays flat, the valuation multiple that carried IBM to its June record may be hard to justify. UBS, for example, has a far more cautious view, with a price target of $236 and a bull case of $312 that assumes software growth accelerates and margins expand.
Competition is another risk. IBM competes with larger cloud and AI platforms, and some analysts have questioned whether AI coding tools could eventually pressure parts of its software and services revenue. The mainframe business also remains cyclical, and a prolonged downturn in that segment would weigh on results.
Wall Street views IBM as a moderate buy on average, but targets have drifted lower since the July warning. The post-drop consensus price target has hovered near $257, while the most bullish firms—Wedbush, Goldman Sachs, RBC Capital, and Evercore—maintained targets in the $340 to $370 range before the guidance cut. A $350 objective therefore sits above the consensus but within the range of the more optimistic analysts.
From a technical analysis perspective, $199 marks a key support level from the July low, while the $300 round number and the $329–$332 record zone serve as major resistance levels IBM would need to clear decisively before a sustained move toward $350 becomes plausible.
For traders monitoring whether IBM can sustain a recovery toward higher price levels, AI Daily Buy/Sell Signals offer a data-driven way to track changing conditions. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on market behavior, technical patterns, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify shifting market trends more efficiently than manual screening alone. Exploring these AI-generated signals can help investors stay informed as conditions evolve.
A move to $350 is not out of reach, but it is ambitious. The strongest supporting factors are IBM's durable free cash flow, its software-led strategy, and its early position in quantum computing. The primary risks are the software slowdown, a still-weak consulting segment, and a valuation that investors may resist until growth reaccelerates. Reaching $350 would most likely require software growth to return to double digits, a stabilization in consulting, and a broader market willing to pay a higher multiple for enterprise AI exposure. Investors should watch quarterly software results, the AI backlog, free cash flow, and the stock's behavior around the $300 and $329–$332 resistance levels.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IBM has been loosely correlated with DXC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IBM jumps, then DXC could also see price increases.
| Ticker / NAME | Correlation To IBM | 1D Price Change % | ||
|---|---|---|---|---|
| IBM | 100% | -0.48% | ||
| DXC - IBM | 50% Loosely correlated | +5.05% | ||
| GIB - IBM | 49% Loosely correlated | +1.24% | ||
| ACN - IBM | 46% Loosely correlated | -1.94% | ||
| HCKT - IBM | 46% Loosely correlated | +0.37% | ||
| INFY - IBM | 45% Loosely correlated | -2.54% | ||
More | ||||
| Ticker / NAME | Correlation To IBM | 1D Price Change % |
|---|---|---|
| IBM | 100% | -0.48% |
| Technology Services category (400 stocks) | 14% Poorly correlated | +0.30% |